Potential home run?Hey guys, I came across this stock pick from a friend. I did a lot of due diligence and even watched their Q3 earnings presentation. I see that covid-19 tests helped their cash situation in Q3 significantly and must have also in Q4. They're expecting to launch Aristotle in Q1 2021 so either February or March since January is almost done. I never invested in bio companies cause I think they're all full of garbage that just have promises, but I'm thinking twice with this one because they're going to launch a product that they've spent 20 years of R&D. I think I might add a significant position and risk a lot of money here. Any thoughts??